Clinical Trials Browser

Gastric Cancer Peritoneal Metastases × Hyperthermic Intraperitoneal Chemotherapy × Gastrointestinal × Clear all

NCT07304258 2025-12-26

A Prospective, Phase II Clinical Study of HIPEC Combined With NIPS and Tislelizumab Conversion Therapy for Gastric Cancer With Peritoneal Metastasis With Positive Cytology Alone or PCI Score ≤10

Phase 2 Not yet recruiting

Gastrointestinal

Gastric Cancer Peritoneal Metastases